SunnyPoint
  • Home
  • About
    • Recent Readings
  • Media
    • Authorship/Mentions
  • Blog
    • Brave Bull Updates
    • The Brave Bull
    • Everything Me
  • Connect
    • Social Media Presence
    • Contact
  • Subscribe
  • Pro Bono
  • Market Takes
  • Tech Takes

One of our recommendation scoops up the other!

7/15/2015

Comments

 
On March 20th 2015, I shared my 2 best picks (and largest positions) in the biotech sector (1 in large cap & 1 in speculative): i.e. Celgene & Receptos.

Link: https://goo.gl/6rl5da

Yesterday CELG bought out RCPT for a price that I’d call is ‘throw-away cheap’. CELG is up almost 9% today and RCPT is up ~50% from when I recommended.  

If you missed it, CELG also announced its preliminary Q2 results, with a beat on both top & bottom line; along with raising its full year guidance. At hardly 21-22x forward P/E (with persistent 25% growth - comes with similar top line growth) and with new potential billion dollar drugs in late stage trials, we bought some more at 132 today. 


With our 2015 end target of $158, I’d say..add on!

Caching!

P.S.: As always, you can get our real time alerts on our moves by subscribing at: http://goo.gl/thTtvo



Select slides from Celgene's presentation: 
Picture
Picture
Comments

    Brave Bull

    Tells you what the Mr. Market is missing. 

    Archives

    January 2022
    January 2021
    July 2018
    June 2018
    December 2017
    June 2017
    December 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    September 2015
    August 2015
    July 2015

    Categories

    All

    View my profile on LinkedIn

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Home
  • About
    • Recent Readings
  • Media
    • Authorship/Mentions
  • Blog
    • Brave Bull Updates
    • The Brave Bull
    • Everything Me
  • Connect
    • Social Media Presence
    • Contact
  • Subscribe
  • Pro Bono
  • Market Takes
  • Tech Takes